Xu-Jie Zhou Selected Research

Xu-Jie Zhou Research Topics

Disease

18	IGA Glomerulonephritis (IGA Nephropathy) 04/2024 - 05/2014
10	Proteinuria 02/2024 - 11/2018
7	Lupus Nephritis 01/2023 - 09/2014
6	Breast Neoplasms (Breast Cancer) 03/2022 - 08/2017
5	Infections 04/2024 - 05/2017
5	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2023 - 05/2017
5	Neoplasms (Cancer) 01/2022 - 08/2017
4	Glomerulonephritis 05/2024 - 05/2019
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023 - 11/2018
4	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 05/2011
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2023 - 11/2018
3	Nephritis 11/2023 - 01/2019
3	Fibrosis (Cirrhosis) 12/2021 - 02/2020
2	Hematuria 03/2024 - 01/2020
2	Hereditary Nephritis (Alport Syndrome) 03/2024 - 09/2022
2	Kidney Diseases (Kidney Disease) 01/2023 - 01/2020
2	Wounds and Injuries (Trauma) 01/2023 - 12/2018
2	Disease Susceptibility (Diathesis) 01/2023 - 01/2017
2	Chronic Renal Insufficiency 01/2022 - 06/2018
2	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2017
2	Atrophy 01/2021 - 02/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020 - 01/2019
2	Inflammation (Inflammations) 11/2020 - 03/2018
2	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 05/2011 - 01/2010
1	Endocarditis 05/2024
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 11/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Ischemia 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Genetic Risk Score 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Acute Tubulointerstitial Nephritis 11/2020
1	Thrombotic Microangiopathies 02/2020
1	Castleman Disease (Castleman's Disease) 02/2020
1	Loeys-Dietz Syndrome 05/2019
1	Acute Kidney Injury (Acute Renal Failure) 05/2019
1	Fever (Fevers) 05/2019

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin A (IgA)IBA 12/2023 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2018
5	CreatinineIBA 01/2023 - 06/2018
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2015
4	AlbuminsIBA 01/2022 - 11/2018
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2024 - 06/2012
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 05/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 06/2018
3	Messenger RNA (mRNA)IBA 11/2021 - 08/2017
3	Amino Acids FDA Link 11/2018 - 05/2011
2	Antigen-Antibody Complex (Immune Complex)IBA 05/2024 - 12/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2023 - 01/2023
2	Complement System Proteins (Complement)IBA 01/2023 - 12/2021
2	Phospholipase A2 ReceptorsIBA 01/2023 - 05/2017
2	N-methyladenosineIBA 03/2022 - 01/2021
2	LipidsIBA 01/2022 - 01/2022
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 10/2017
2	galactosyl-deficient IgA1IBA 01/2022 - 01/2021
2	HomocysteineIBA 01/2022 - 02/2020
2	Genetic Markers (Genetic Marker)IBA 01/2021 - 05/2014
2	AntibodiesIBA 05/2019 - 11/2018
2	Rituximab (Mabthera)FDA Link 05/2019 - 06/2018
2	NPHS2 proteinIBA 01/2019 - 12/2018
2	Immunoglobulins (Immunoglobulin)IBA 11/2018 - 11/2018
2	Small Interfering RNA (siRNA)IBA 10/2017 - 08/2017
2	DefensinsIBA 01/2016 - 06/2012
2	HLA-DRB1 Chains (HLA DRB1)IBA 05/2011 - 01/2010
1	Blood Proteins (Serum Proteins)IBA 04/2024
1	ProteomeIBA 04/2024
1	Hepatitis B AntigensIBA 04/2024
1	Interferon Type IIBA 03/2024
1	Sodium-Glucose Transporter 2IBA 03/2024
1	Mineralocorticoid Receptor AntagonistsIBA 03/2024
1	InterleukinsIBA 11/2023
1	Uric Acid (Urate)IBA 01/2023
1	pristane (pristan)IBA 01/2023
1	anticomplementIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Complement Factor H (Factor H)IBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	dapagliflozinIBA 09/2022
1	CreatineIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	LectinsIBA 12/2021
1	6-methyladenineIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	CC ChemokinesIBA 01/2021
1	SteroidsIBA 12/2020
1	C-Reactive ProteinIBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020
1	Viral AntigensIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019
1	Transforming Growth Factor-beta Type II ReceptorIBA 05/2019
1	myotubularinIBA 01/2019
1	Drug CombinationsIBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019

Therapy/Procedure

8	Therapeutics 04/2024 - 01/2018
1	Plasma Exchange 05/2019